Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.

Willis, M D; Robertson, N P

Willis, M D; Robertson, N P.

Willis MD; Department of Neurology, University Hospital Wales, Cardiff, CF14 4XN, UK.
Robertson NP; Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.

J Neurol ; 267(5): 1567-1569, 2020 05.

Article in English | MEDLINE | ID: covidwho-72121

Subject(s)

Coronavirus; Multiple Sclerosis; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; COVID-19; Coronavirus Infections; Fingolimod Hydrochloride; Humans; Natalizumab; Pandemics; Pneumonia, Viral; Rituximab; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Severe acute respiratory syndrome-related coronavirus / Multiple Sclerosis Type of study: Prognostic study Limits: Humans Language: English Journal: J Neurol Year: 2020 Document Type: Article Affiliation country: S00415-020-09822-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google